Teriparatide in the treatment of non-unions: scientific and clinical evidences (Q44543490)

4 December 2017

Teriparatide in the treatment of non-unions: scientific and clinical evidences (English)

1 reference

4 December 2017

Luca Pietrogrande

1

1 reference

PubMed ID

23351873

4 December 2017

Emanuela Raimondo

series ordinal

2

1 reference

PubMed ID

23351873

4 December 2017

language of work or name

1 reference

1 January 2013

1 reference

4 December 2017

1 reference

4 December 2017

44 Suppl 1

1 reference

4 December 2017

S54-7

1 reference

The epidemiology of fractures in England.

4 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2813%2970013-5

Definition and classification of fracture non-unions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2813%2970013-5

Parathyroid hormone and bone healing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2813%2970013-5

Risk factors contributing to fracture non-unions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2813%2970013-5

Evidence for anti-osteoporosis therapy in acute fracture situations--recommendations of a multidisciplinary workshop of the International Society for Fracture Repair

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2813%2970013-5

Effects of estrogen on fracture healing in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2813%2970013-5

Implications for fracture healing of current and new osteoporosis treatments: an ESCEO consensus paper

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2813%2970013-5

Characterization and evaluation of asymptomatic primary hyperparathyroidism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2813%2970013-5

Treatment with human parathyroid hormone (1-34) for 18 months increases cancellous bone volume and improves trabecular architecture in ovariectomized cynomolgus monkeys (Macaca fascicularis)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2813%2970013-5

Teriparatide [PTH(1-34)] strengthens the proximal femur of ovariectomized nonhuman primates despite increasing porosity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2813%2970013-5

Efficacy and Safety of Human Parathyroid Hormone-(1–84) in Increasing Bone Mineral Density in Postmenopausal Osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2813%2970013-5

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2813%2970013-5

Intermittent parathyroid hormone (1-34) treatment increases callus formation and mechanical strength of healing rat fractures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2813%2970013-5

Enhancement of Experimental Fracture-Healing by Systemic Administration of Recombinant Human Parathyroid Hormone (PTH 1-34)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2813%2970013-5

Combined effects of recombinant human BMP-7 (rhBMP-7) and parathyroid hormone (1-34) in metaphyseal bone healing.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2813%2970013-5

Human parathyroid hormone (1-34) accelerates the fracture healing process of woven to lamellar bone replacement and new cortical shell formation in rat femora.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2813%2970013-5

Human parathyroid hormone (1-34) accelerates natural fracture healing process in the femoral osteotomy model of cynomolgus monkeys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2813%2970013-5

Effects of OP-1 and PTH in a new experimental model for the study of metaphyseal bone healing.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2813%2970013-5

Fracture healing in the elderly patient.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2813%2970013-5

Effect of osteoporosis on bone mineral density and fracture repair in a rat femoral fracture model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2813%2970013-5

Changes of microstructure and mineralized tissue in the middle and late phase of osteoporotic fracture healing in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2813%2970013-5

Parathyroid hormone treatment increases fixation of orthopedic implants with gap healing: a biomechanical and histomorphometric canine study of porous coated titanium alloy implants in cancellous bone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2813%2970013-5

Effect of intermittent parathyroid hormone (1-34) treatment on the bone response after placement of titanium implants into the tibia of ovariectomized rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2813%2970013-5

Early effect of parathyroid hormone (1-34) on implant fixation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2813%2970013-5

Implant fixation enhanced by intermittent treatment with parathyroid hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2813%2970013-5

Intermittent parathyroid hormone (1-34) enhances mechanical strength and density of new bone after distraction osteogenesis in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2813%2970013-5

Intermittent parathyroid hormone treatment enhances guided bone regeneration in rat calvarial bone defects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2813%2970013-5

Sequential treatment with intermittent low-dose human parathyroid hormone (1-34) and bisphosphonate enhances large-size skeletal reconstruction by vascularized bone transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2813%2970013-5

Teriparatide for acceleration of fracture repair in humans: a prospective, randomized, double-blind study of 102 postmenopausal women with distal radial fractures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2813%2970013-5

Parathyroid hormone 1-84 accelerates fracture-healing in pubic bones of elderly osteoporotic women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2813%2970013-5

Teriparatide may accelerate healing in delayed unions of type III odontoid fractures: a report of 3 cases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2813%2970013-5

Enhanced healing of sacral and pubic insufficiency fractures by teriparatide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2813%2970013-5

[Parathyroid hormone injection to counteract delayed bone fractures]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2813%2970013-5

Teriparatide, a nonsurgical solution for femoral nonunion? A report of three cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2813%2970013-5

Atrophic humeral shaft nonunion treated with teriparatide (rh PTH 1-34): a case report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2813%2970013-5

Successful treatment of sternal fracture nonunion with teriparatide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2813%2970013-5

Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2813%2970013-5

Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2813%2970013-5

Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2813%2970013-5

Endogenous PTH deficiency impairs fracture healing and impedes the fracture-healing efficacy of exogenous PTH(1-34).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2813%2970013-5

10.1016/S0020-1383(13)70013-5

7 January 2021

Identifiers

DOI

1 reference

4 December 2017

1 reference

PubMed ID

23351873